We hypothesized that HOPX expression status could be predicted using CT image-based radiogenomics or imaging biopsy, and a radiogenomic signature associated with HOPX expression could provide us with the prognostic power for stratification of patients with NSCLC into high- and low-risk groups. This evidence concerns the gene HOPX and non-small cell lung carcinoma.